Headache News

Veteran patients and health care providers felt complementary and integrative medicine was a safe addition to mainstream treatment options for headache management, researchers reported in BMC Complementary Medicine and Therapies.

Former college football players had a significantly higher prevalence of several health issues later in life than nonplayers, according to findings published in JAMA Network Open.

SEATTLE — COVID-19, caused by SARS-CoV-2 infection, is linked to a wide range of conditions that affect neurological processes, according to an expert at the 2022 American Academy of Neurology annual meeting.

SEATTLE — Trudhesa was effective in treating migraines of varying severity, a speaker said at the 2022 American Academy of Neurology annual meeting.

Natalia S. Rost, MD, MPH, chair of the AAN science committee, led a discussion to highlight select studies being presented at the AAN’s annual meeting April 2-7 in Seattle.

Concussion was linked to increased risk for mental health issues, psychiatric hospitalization and self-harm among youths aged 5 to 18 years, according to results of a population-based retrospective cohort study.

In a noninferiority randomized trial, the antidepressants amitriptyline and venlafaxine significantly reduced the number of migraine attacks per month, according to researchers.

Pregnancies complicated by migraines are associated with adverse outcomes for both women and their babies, according to a presentation at The Pregnancy Meeting.

Commercial-stage bioelectronic medicine company electroCore Inc. announced its noninvasive vagus nerve stimulation intervention for migraine prevention reduced the number of monthly headache days.

Neuroscience specialty pharmaceutical company OWP Pharmaceuticals Inc. has partnered with Eversana, a provider of global services to the life sciences industry, to launch oral liquid formulations for treating neuroscience disorders.